At a glance
ClinicalIndex Comparison RecordN/ACompleted· 376 enrolled
Drug / intervention
Activ-L Artificial Disc +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study to Evaluate the Safety and Effectiveness of the Aesculap Activ-L™ Artificial Disc in the Treatment of Degenerative Disc Disease
In Brief
A clinical study evaluating Activ-L Artificial Disc and ProDisc-L Total Disc Replacement or Charité Artificial Disc for Degenerative Disc Disease. Completed, enrolled 376 participants across 17 sites.
Detailed Summary
The purpose of this study is to learn whether an investigational device called the Activ-L Artificial Disc is safe and effective in the treatment of degenerative disc disease of the lower (lumbar) spine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDegenerative Disc Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2007
First PostedJan 2008
Primary CompletionDec 2012
Study CompletionJan 2017
TodayJul 2026
First PostedJan 10, 2008
Enrollment StartJan 1, 2007
Primary CompletionDec 1, 2012
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 18.5 years ago
Interventions
Activ-L Artificial Discdevice
Implantation at one level of the lumbar spine, either L4/L5 or L5/S1.
ProDisc-L Total Disc Replacement or Charité Artificial Discdevice
Implantation at one level of the lumbar spine, either L4/L5 or L5/S1.